Navigation Links
High development costs hinder entry of cancer super drugs into the market

Cancer patients in the future could benefit from pharmacogenomics or the field of personalized medicine where therapies could be tailored to suit individual patients. Few drugs which target specific protein receptors in cancer are already in the market and the decoding of the human genome// offers great promise to patients, as the therapy could become more specialized. However, all this comes with a heavy cost and cancer research experts warn that such breakthroughs may not lead to new treatment due to the cost.

Pharmaceutical companies face formidable problems in this new treatment approach as it costs about $100 million to develop a cancer drug and only about one in ten make it to the market. The developmental costs of these drugs are so high because they are targeted at specific molecules and this requires sophisticated screening tests.

The pharma companies are already pulling out of oncology drugs since the potential market is too small, as the patients treated with a particular drug are confined to a small genetically defined subgroup, and the sales from this small group would not cover the development costs. Unless scientists are able to show that these drugs work on a specific genetic type instead of on only 2 or 3 per cent of patients, these drugs may not make it to the market.

A cancer research expert, Dr. Keith Snell warned that if development costs are not reduced, the new cancer therapies have very slim chances of reaching the cancer patients. He however suggested that the solution lies in simplifying clinical trials and small biotechnology companies, major drug companies and scientific researchers agreeing to share the risks, thereby making the development process a more economic proposition.


'"/>




Page: 1

Related medicine news :

1. Cancer drugs in development nearly doubled since 1995
2. Role of zinc in development
3. Particulate matter affects lung development
4. Fossil teeth and human development
5. Fireflies help speed development of new drugs
6. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
7. New fertility drug development techniques by Organon
8. Biosensor chip to help drug development
9. Cells critical for asthma development found
10. ICMR along with other International Research organisation with drug development for Neglected Diseases
11. Epilepsy surgery to help child development
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD ... dose required and providing a CBD form that can be easily incorporated into liquid ...
(Date:10/13/2017)... ... 2017 , ... Apple Rehab Shelton Lakes , which specializes in the ... facility as part of a disaster drill on October 3rd. , Apple Rehab participated ... Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid Plan ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017  AllianceRx Walgreens Prime, the combined ... Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), ... which included the unveiling of new signage at its ... well as at a few other company-owned facilities across ... to patients, some of whom will begin to see ...
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: